Miconazole Buccal Tablets (Oravig)

Elliott, William T.; Chan, James
May 2010
Internal Medicine Alert;5/29/2010, Vol. 32 Issue 10, p6
The article offers information on the Oravig miconazole buccal tablet approved by the U.S. Food and Drug Administration (FDA) for the treatment of oropharyngeal candidiasis.


Related Articles

  • Neonatal systemic candidiasis treated with miconazole. Clarke, M.; Davies, D.P.; Odds, F.; Mitchell, C. // British Medical Journal;8/2/1980, Vol. 281 Issue 6236, p354 

    Examines the effect of miconazole in the treatment of neonatal systemic candidiasis. Management for neonatal apnea; Isolation of candidiasis albicans from the mouth and groin area; Inhibitory concentration for miconazole.

  • Fluconazole: Most cost-effective vaginal candidiasis treatment, modeling study finds.  // Formulary;Mar1999, Vol. 34 Issue 3, p278 

    Compares different antifungal medications used in treating vaginal candidiasis. Goal of reducing nursing administration time, biological waste, soiling of clothing and bedding; Drug acquisition costs for fluconazole, nystatin, clotrimazole and miconazole.

  • ORAVIG.  // Nurse Practitioners Prescribing Reference;Winter2010/2011, Vol. 17 Issue 4, pA.16 

    The article offers information on the Oravig miconazole buccal tablets from Strativa Pharmaceuticals, which is used for the treatment of oropharyngeal candidiasis (OPC).

  • Preparation and Pharmaceutical Evaluation of Miconazole Nitrate Mucoadhesive Films for Vaginal Candidiasis. Najafi, Rahim Bahri; Maghrouri, Zahra; Peikanpour, Mohammad // Journal of Isfahan Medical School;Feb2013, Vol. 30 Issue 216, p2103 

    Background: Mucoadhesive dosage forms including tablets, gels, ointments, patches, and films have received great attention during recent years. They facilitate the topical release and hence better absorbance of the drug. We tried to design miconazole nitrate mucoadhesive films to affect vaginal...

  • Managing vulvovaginal candidiasis. Aziz, Zara // Independent Nurse;2/1/2010, p32 

    The article focuses on the proper management of vulvovaginal candidiasis. It mentions that one of the causes of this condition is fungal organism that is present in the different body parts like the skin, mouth and the gastrointestinal tract. Among its symptoms are vulval inflammation, vaginal...

  • miconazole. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p505 

    An encyclopedia entry for "miconazole" is presented. It is an antifungal drug used topically in the form of creams, ointments or powder for the treatment of tinea skin infections such as athlete's foot, or as vaginal suppositories for vaginal candidiasis. In rare cases, miconazole can cause a...

  • Oravig.  // Formulary;Jun2010, Vol. 45 Issue 6, p178 

    The article discusses the approval by the U.S. Food and Drug Administration (FDA) of the oral antifungal drug Oravig, formulated as a miconazole buccal tablet.

  • BioAlliance submits IND for OPC treatment.  // European Pharmaceutical Executive;Sep/Oct2005, p12 

    Reports that biopharmaceutical company BioAlliance Pharma SA has submitted an Investigational New Drug Application to the U.S. Food and Drug Administration to conduct a Phase III clinical trial of its antifungal agent, miconazole Lauriad. Potential of the drug as a treatment for oropharyngeal...

  • News from the FDA. Asch-Goodkin, Judith; Kaplan, Deborah // Patient Care;Dec2006, Vol. 40 Issue 12, p10 

    The article offers news briefs on drugs approved by the U.S. Food & Drug Administration (FDA). The agency has approved Aricept, donepezil hydrochloride, used to treat mild, moderate, and severe forms of dementia from Alzheimer's disease. Noxafil, posaconazole, was approved for the treatment of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics